Parsemus Foundation News Today

Researchers in Virginia who injected 23 men with the non-hormonal birth control - called ADAM - said sperm counts in participants ejaculations dropped by 99 to 100 percent just a month after the procedure.

Contraline released promising data from the clinical trial it’s conducting to test the efficacy of Adam, its male birth control product. The nonhormonal gel seems to be doing a good job of blocking the flow of sperm to the vas deferens, and no serious adverse events have been reported.

Using low-dose aspirin was associated with a 20% increased incidence of anemia and decline in ferritin, or blood iron levels, in otherwise healthy older adults, according to a new analysis of an old study.

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

/PRNewswire/ -- A new study published in The Lancet Infectious Diseases supported by the Parsemus Foundation found a 41% reduction in Long COVID rates among...

MINNEAPOLIS, June 9, 2023 /PRNewswire/ -- A new study published in The Lancet Infectious Diseases supported by the Parsemus Foundation found a 41% reduction in Long COVID rates among people

/PRNewswire/ -- After years in development by the Parsemus Foundation, NEXT Life Sciences, Inc. has announced its plans to bring a new contraceptive product to...

Heather Vahdat has been advocating for male contraceptive options for nearly a decade, but she is the first to say it is a lonely space to occupy in the health science field. Vahdat is the …

New male contraceptive options are in development to meet increased demand after Roe v. Wade was overturned.

At the moment, the options for men are limited to condoms and vasectomies, Vahdat said, and while vasectomies can potentially be reversed, it doesn’t always work.